Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) Non Operating Income (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Non Operating Income data on record, last reported at $6.5 million in Q4 2025.

  • For Q4 2025, Non Operating Income rose 98.78% year-over-year to $6.5 million; the TTM value through Dec 2025 reached $1.6 million, up 66.22%, while the annual FY2025 figure was $974000.0, 0.31% changed from the prior year.
  • Non Operating Income reached $6.5 million in Q4 2025 per PTCT's latest filing, up from -$6.3 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $84.4 million in Q4 2022 and bottomed at -$38.1 million in Q3 2022.
  • Average Non Operating Income over 5 years is -$3.1 million, with a median of -$1.9 million recorded in 2024.
  • The widest YoY moves for Non Operating Income: up 368.85% in 2022, down 1184.5% in 2022.
  • A 5-year view of Non Operating Income shows it stood at -$31.4 million in 2021, then skyrocketed by 368.85% to $84.4 million in 2022, then crashed by 88.76% to $9.5 million in 2023, then crashed by 65.43% to $3.3 million in 2024, then skyrocketed by 98.78% to $6.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $6.5 million in Q4 2025, -$6.3 million in Q1 2025, and $3.3 million in Q4 2024.